Scott Zook is the Senior Vice President, Global Manufacturing and brings more than 28 years of drug development experience in the pharmaceutical industry consisting of establishing and directing CMC strategy and activities, developing global supply chains, and managing a wide range of drug candidates across all regulatory phases. Prior to joining Primmune Therapeutics, Mr. Zook was Vice President of CMC at Neurocrine Biosciences, where he was responsible for managing the development and manufacturing efforts for drug development programs, which included two NDA approvals and covered a wide range of therapeutic areas, including neurology, gene therapy, endocrinology, pediatric and adult epilepsy, and neuro-psychiatric conditions. Prior to joining Neurocrine Biosciences, Mr. Zook was a scientist at Agouron Pharmaceuticals (acquired by Pfizer), where he led the API efforts on VEGF oncology and VEGF ophthalmology products. Mr. Zook earned his M.Sc. in synthetic organic chemistry and B.Sc. in organic chemistry from the University of Saskatchewan.
Scott Zook
